FDA Application
-
NDC Search Results on Active Ingredient: fluticasone propionate
Click on Active Ingredient to view the label.
| Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
|---|---|---|---|---|---|
| FLUTICASONE PROPIONATE | 37835-997-31 | Bi-Mart | ANDA208150 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 30142-258-04 | Kroger Company | ANDA208150 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 63654-380-01 | Selder, S.A. de C.V. | ANDA208150 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 68998-600-01 | Marc Glassman, Inc. | ANDA208150 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 68196-210-01 | Sam's West Inc. | ANDA208150 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 49035-063-01 | Walmart | ANDA208150 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 49035-362-04 | Walmart | ANDA208150 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 69842-765-03 | CVS Pharmacy | ANDA208150 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 69168-380-02 | Allegiant Health | ANDA208150 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 68196-503-01 | Sam's West Inc. | ANDA208150 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 70518-2501-0 | REMEDYREPACK INC. | ANDA208891 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0378-9322-32 | Mylan Pharmaceuticals Inc. | ANDA208891 | HUMAN PRESCRIPTION DRUG | ANDA |
| SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 0378-9321-32 | Mylan Pharmaceuticals Inc. | ANDA208891 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0378-9320-32 | Mylan Pharmaceuticals Inc. | ANDA208891 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0093-7517-31 | Teva Pharmaceuticals USA, Inc. | ANDA213948 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0093-7518-31 | Teva Pharmaceuticals USA, Inc. | ANDA213948 | HUMAN PRESCRIPTION DRUG | ANDA |
| SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 0093-7516-31 | Teva Pharmaceuticals USA, Inc. | ANDA213948 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 58602-018-42 | Aurohealth LLC | ANDA217088 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 58602-017-43 | Aurohealth LLC | ANDA217088 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 66993-790-97 | Prasco Laboratories | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| FLUTICASONE PROPIONATE | 0173-0602-02 | GlaxoSmithKline LLC | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE | 66993-791-97 | Prasco Laboratories | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| FLUTICASONE PROPIONATE | 50090-1245-0 | A-S Medication Solutions | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE | 50090-7076-0 | A-S Medication Solutions | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| FLUTICASONE PROPIONATE | 63187-957-60 | Proficient Rx LP | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE | 66993-792-97 | Prasco Laboratories | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| FLUTICASONE PROPIONATE | 0173-0601-02 | GlaxoSmithKline LLC | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE | 76519-1177-0 | H.J. Harkins Company, Inc. | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE | 0173-0600-02 | GlaxoSmithKline LLC | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0173-0695-04 | GlaxoSmithKline LLC | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA |
| 1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-180 | 181-210 | 211-240 | 241-270 | 271-300 |
| 301-330 | 331-360 | 361-390 | 391-420 | 421-426 |
-
